HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes

Hepatology Research

Volumn 39, Issue 4, 2009, Pages 355-365

  Chen, Weiwei ^a   Shi, Ming ^b   Shi, Feng ^b   Mao, Yuanli ^a   Tang, Zirong ^b   Zhang, Bin ^b   Zhang, Hui ^b   Chen, Liangen ^b   Chen, Liming ^b   Xin, Shaojie ^c   Wang, Fu Sheng ^b  

^a National Center for Clinical Laboratory   (China)

^b Institute of Infectious Diseases   (China)

^c BEIJING 302 HOSPITAL   (China)

Author keywords

Chronic hepatitis B; Dendritic cells; Hepatitis B virus; Polarization; T helper cell

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HLA A24 ANTIGEN; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POLARITY; CELL SPECIFICITY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPOIESIS; MALE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

EID: 63649095194     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00468.x     Document Type: Article

References (46)

1. Ganem D, Prince AM. Hepatitis b virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
2. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2: 43-50.
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-29.
4. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis 2003; 23: 21-38.
5. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003; 38: 4-13.
6. Kakimi K, Isogawa M, Chung J, Sette A, Chisari FV. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections. J Virol 2002; 76: 8609-20.
7. Steinman RM, Hemmi H. Dendritic cells: Translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17-58.
8. Zheng BJ, Zhou J, Qu D et al. Selective functional deficit in dendritic cell - T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004; 11: 217-24.
9. Beckebaum S, Cicinnati VR, Zhang X et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: Mechanisms for viral immune escape. Immunology 2003; 109: 487-95.
10. Wang FS, Xing LH, Liu MX et al. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001; 7: 537-41.
11. van der Molen RG, Sprengers D, Binda RS et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-46.
12. Mizukoshi E, Sidney J, Livingston B et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004; 173: 5863-71.
13. Szkaradkiewicz A, Jopek A, Wysocki J. Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 2005; 66: 23-7.
14. Akbar SM, Furukawa S, Horiike N et al. Vaccine therapy for hepatitis B virus carrier. Curr Drug Targets Infect Disord 2004; 4: 93-101.
15. Shimada N, Yamamoto K, Kuroda MJ et al. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol 2003; 23: 223-32.
16. Zhang Y, Li S, Shan M et al. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8(+) T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 2007; 121: 105-12.
17. Tang TJ, de Man RA, Kusters JG et al. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients. J Med Virol 2004; 72: 215-22.
18. Chong CS, Cao M, Wong WW et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release 2005; 102: 85-99.
19. Lau GK, Suri D, Liang R et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002; 122: 614-24.
20. Shi M, Qian S, Chen WW et al. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2007; 147: 277-86.
21. Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect 2005; 11: 52-6.
22. Lehner M, Morhart P, Stilper A, Holter W. Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions. Immunol Lett 2005; 99: 209-16.
23. Chen Y, Yang C, Jin N et al. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization. Eur J Immunol 2007; 37: 167-76.
24. Ludewig B, Hoffmann MW. Adoptive immunotherapy: Methods and protocols. Methods in Molecular Medicine. Totowa, NJ: Humana Press, 2005.
25. Lecoeur H, Février M, Garcia S, Rivière Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 2001; 253: 177-87.
26. Tsai SL, Sheen IS, Chien RN et al. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications. J Biomed Sci 2003; 10: 120-35.
27. Boni C, Bertoletti A, Penna A et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102: 968-75.
28. Szkaradkiewicz A, Jopek A, Wysocki J, Grzymislawski M, Malecka I, Wozniak A. HBcAg-specific cytokine production by CD4 T lymphocytes of children with acute and chronic hepatitis B. Virus Res 2003; 97: 127-33.
29. Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999; 29: 971-5.
30. Liaw YF, Leung NW, Chang TT et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000; 119: 172-80.
31. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th 2 cytokines. Immunity 1995; 2: 271-9.
32. Carter LL, Dutton RW. Type 1 and type 2: A fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996; 8: 336-42.
33. Inui N, Chida K, Suda T, Nakamura H. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 2001; 107: 337-44.
34. de Jong EC, Vieira PL, Kalinski P et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002; 168: 1704-9.
35. d'Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000; 191: 1661-74.
36. Vieira PL, de Jong EC, Wierenga EA et al. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000; 164(9): 4507-12.
37. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-93.
38. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006; 6: 476-83.
39. Shimizu Y, Guidotti LG, Fowler P, Chisari FV. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998; 161: 4520-9.
40. Oka Y, Akbar SM, Horiike N, Joko K, Onji M. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 2001; 103: 90-7.
41. Huang Y, Chen Z, Jia H et al. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clin Immunol 2006; 119: 280-90.
42. Fazle Akbar SM, Furukawa S, Onji M et al. Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers. Hepatol Res 2004; 29: 136-41.
43. Akbar SM, Furukawa S, Hasebe A, Horiike N, Michitaka K, Onji M. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer. Int J Mol Med 2004; 14: 295-9.
44. Milich DR, Schödel F, Hughes JL, Jones JE, Peterson DLL. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 1997; 71: 2192-201.
45. Bertoletti A, Southwood S, Chesnut R et al. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptor. Hepatology 1997; 26: 1027-34.
46. Livingston BD, Crimi C, Fikes J, Chesnut RW, Sidney J, Sette A. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules. Hum Immunol 1999; 60: 1013-17.